This revised R01 grant application is focused on the study of T cell responses in HIV infected children. The course of HIV infection in children differs from adults, with many children experiencing higher and more persistent levels of HIV viremia. This could be related to the immaturity of the infant immune system or other immunological factors. In 3 specific aims, we undertake to understand more about the host pathogen interaction in HIV infected children, and how antiretroviral drugs affect these responses. In the first specific aim, we will determine the ability of young HIV uninfected children to mount T cell responses. We will study HIV infected children under 5 to determine the magnitude and breadth of HIV specific CD4+ and CD 8+ T cell responses. We show preliminary data that CD4+CD25+ T regulatory (Treg) cells can specifically suppress HIV specific responses and we will ascertain whether suppression of virus specific T cell responses might be due to higher Treg activity in these young children. There have been very few studies of differences in HIV immune responsiveness between racial groups. We present preliminary data that shows that Blacks have higher HIV specific T cell immune responses than Hispanics, when matched by age, viral load and CD4+ T cell count/percentage. In the second specific aim we will investigate how HLA and other genetic factors affect these results, if HIV specific immune responsiveness is related to the degree of racial admixing, and if other genetic, virologic or environmental factors could contribute to differential responses. Finally, as the HIV infected population in the USA matures into adolescence, we will perform an observational longitudinal study in the third specific aim to determine how levels of HIV specific immunity vary over time in relation to drug treatment, drug resistance and viral fitness. The goal of this grant application is to better understand immunopathogenic factors relevant to HIV infected children so they can be better placed to take advantage of developments in vaccines and new treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI060379-03
Application #
7173794
Study Section
Special Emphasis Panel (ZRG1-AARR-C (02))
Program Officer
Plaeger, Susan F
Project Start
2005-04-15
Project End
2009-12-31
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$312,134
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Sanabani, Sabri Saeed; Pessoa, Rodrigo; Soares de Oliveira, Ana Carolina et al. (2013) Variability of HIV-1 genomes among children and adolescents from Sao Paulo, Brazil. PLoS One 8:e62552
Sharp, Elizabeth R; Willberg, Christian B; Kuebler, Peter J et al. (2012) Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children. PLoS One 7:e29154
Carvalho, Karina I; Bruno, Fernanda R; Snyder-Cappione, Jennifer E et al. (2012) Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology 136:96-102
Ndhlovu, Lishomwa C; Lopez-Vergès, Sandra; Barbour, Jason D et al. (2012) Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119:3734-43
Jha, Aashish R; Nixon, Douglas F; Rosenberg, Michael G et al. (2011) Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS One 6:e20234
Sharp, Elizabeth R; Willberg, Christian B; Kuebler, Peter J et al. (2011) Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents. PLoS One 6:e21135
Long, Brian R; Erickson, Ann E; Chapman, Joan M et al. (2010) Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology 129:186-96
Ndhlovu, Lishomwa C; Leal, Fabio E; Eccles-James, Ijeoma G et al. (2010) A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur J Immunol 40:134-41
Carvalho, Karina I; Melo, Karina M; Bruno, Fernanda R et al. (2010) Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PLoS One 5:
Melo, Karina M; Carvalho, Karina I; Bruno, Fernanda R et al. (2009) A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS One 4:e6269

Showing the most recent 10 out of 12 publications